Gross et al., 1994 - Google Patents
Virulence regulation in Bordetella pertussisGross et al., 1994
- Document ID
- 14584568730037053878
- Author
- Gross R
- Fuchs T
- Deppisch H
- Carbonetti N
- Publication year
- Publication venue
- Molecular mechanisms of bacterial virulence
External Links
Snippet
For several years, Bordetella pertussis, the etiological agent of whooping cough, has been the subject of intensive investigations with the aim of developing new vaccines. These studies have revealed much about the complex interactions between the invading pathogen …
- 241000588832 Bordetella pertussis 0 title abstract description 36
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pittman | The concept of pertussis as a toxin-mediated disease | |
Locht | Molecular aspects of Bordetella pertussis pathogenesis | |
Manning | The tcp gene cluster of Vibrio cholerae | |
SI9720050A (en) | Multivalent dtp-polio vaccines | |
Gueirard et al. | Virulence of Bordetella bronchiseptica: role of adenylate cyclase-hemolysin | |
Hausman et al. | Analysis of proteins encoded by the ptx and ptl genes of Bordetella bronchiseptica and Bordetella parapertussis | |
NZ549068A (en) | Virulence genes, proteins, and their use in treating conditions associated with infection by Neisseria or gram-negative bacteria | |
US6387377B1 (en) | Acellular antibordetella vaccine | |
Mooi | Virulence factors of Bordetella pertussis | |
US6309648B1 (en) | Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections | |
Gross et al. | Virulence regulation in Bordetella pertussis | |
Brennan et al. | Recent advances in the development of pertussis vaccines | |
Relman | Bordetella pertussis: determinants of virulence | |
Gross et al. | Differential regulation of Bordetella pertussis virulence factors | |
Rappuoli et al. | Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxin | |
EP0550683A1 (en) | Vaccine suitable for combatting bordetella pertussis. | |
US6030625A (en) | Bordetella pertussis and Bordetella parapertussis strains | |
Rappuoli et al. | BvgAS dependent phenotypic modulation of Bordetella species | |
Keil et al. | Cloning and immunologic characterization of a truncated Bordetella bronchiseptica filamentous hemagglutinin fusion protein | |
Roberts et al. | Bordetella pertussis | |
Hewlett et al. | Adenylyl cyclase toxin from Bordetella pertus-sis | |
Webb et al. | Approaches to the rational design of bacterial vaccines | |
Cox | The cloning and characterization of three genes in Bordetella avium | |
McArthur | Rational attenuation of Bordetella bronchiseptica for vaccine purposes | |
Klein et al. | 1.4 The New Pertussis Vaccines |